This grant is for advancing crucial research into communication strategies for the successful public adoption of future HIV vaccines. As efforts progress to develop safe and effective vaccines to reduce new HIV infections and end the epidemic, public understanding and acceptance are paramount. The current landscape, marked by widespread vaccine skepticism and misinformation, underscores the critical need for effective communication. This initiative aims to identify key communication factors and develop robust strategies to foster public understanding, acceptance, and uptake of future HIV prevention vaccines, combating misinformation and bolstering public health outcomes.
Opportunity ID: 337207
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-MH-22-171 |
Funding Opportunity Title: | Advancing communication strategies to support future HIV vaccine use (R21 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.242 — Mental Health Research Grants |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jan 03, 2022 |
Last Updated Date: | Jan 03, 2022 |
Original Closing Date for Applications: | May 10, 2022 |
Current Closing Date for Applications: | May 10, 2022 |
Archive Date: | Jun 15, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | $275,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | State governments Independent school districts Public and State controlled institutions of higher education For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Private institutions of higher education Native American tribal governments (Federally recognized) Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Native American tribal organizations (other than Federally recognized tribal governments) County governments Public housing authorities/Indian housing authorities Special district governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | Efforts are underway to develop a safe and effective vaccine to protect people from acquiring HIV ultimately reducing the number of new infections and ending the epidemic. However, the subject of vaccines remains contentious, and COVID-19 has heightened the conversation. There are multiple messages circulating both for and against vaccines and a growing number of skeptics appear to be making decisions about vaccines based on misinformation. This initiative will advance research on communication factors and strategies that will be crucial for successful public understanding, acceptance, and uptake of future vaccines that protect against HIV. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-171.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 337207 Full Announcement-RFA-MH-22-171 -> RFA-MH-22-171-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00271209 | Apr 10, 2022 | May 10, 2022 | View |
Package 1
Mandatory forms
337207 RR_SF424_5_0-5.0.pdf
337207 PHS398_CoverPageSupplement_5_0-5.0.pdf
337207 RR_OtherProjectInfo_1_4-1.4.pdf
337207 PerformanceSite_4_0-4.0.pdf
337207 RR_KeyPersonExpanded_4_0-4.0.pdf
337207 PHS398_ResearchPlan_4_0-4.0.pdf
337207 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
337207 RR_Budget_3_0-3.0.pdf
337207 RR_SubawardBudget30_3_0-3.0.pdf
337207 PHS398_ModularBudget_1_2-1.2.pdf
337207 PHS_AssignmentRequestForm_3_0-3.0.pdf